TY - JOUR
T1 - Novel strategy for selection of monoclonal antibodies against highly conserved antigens
T2 - Phage library panning against ephrin-B2 displayed on yeast
AU - Gu, Xiaoling
AU - Vedvyas, Yogindra
AU - Chen, Xiaoyue
AU - Kaushik, Tanwi
AU - Hwang, Chang Il
AU - Hu, Xuebo
AU - Nikitin, Alexander Y.
AU - Jin, Moonsoo M.
PY - 2012/1/23
Y1 - 2012/1/23
N2 - Ephrin-B2 is predominately expressed in endothelium of arterial origin, involved in developmental angiogenesis and neovasculature formation through its interaction with EphB4. Despite its importance in physiology and pathological conditions, it has been challenging to produce monoclonal antibodies against ephrin-B2 due to its high conservation in sequence throughout human and rodents. Using a novel approach for antibody selection by panning a phage library of human antibody against antigens displayed in yeast, we have isolated high affinity antibodies against ephrin-B2. The function of one high affinity binder (named as 'EC8') was manifested in its ability to inhibit ephrin-B2 interaction with EphB4, to cross-react with murine ephrin-B2, and to induce internalization into ephrin-B2 expressing cells. EC8 was also compatible with immunoprecipitation and detection of ephrin-B2 expression in the tissue after standard chemical fixation procedure. Consistent with previous reports on ephrin-B2 induction in some epithelial tumors and tumor-associated vasculatures, EC8 specifically detected ephrin-B2 in tumors as well as the vasculature within and outside of the tumors. We envision that monoclonal antibody developed in this study may be used as a reagent to probe ephrin-B2 distribution in normal as well as in pathological conditions and to antagonize ephrin-B2 interaction with EphB4 for basic science and therapeutic applications.
AB - Ephrin-B2 is predominately expressed in endothelium of arterial origin, involved in developmental angiogenesis and neovasculature formation through its interaction with EphB4. Despite its importance in physiology and pathological conditions, it has been challenging to produce monoclonal antibodies against ephrin-B2 due to its high conservation in sequence throughout human and rodents. Using a novel approach for antibody selection by panning a phage library of human antibody against antigens displayed in yeast, we have isolated high affinity antibodies against ephrin-B2. The function of one high affinity binder (named as 'EC8') was manifested in its ability to inhibit ephrin-B2 interaction with EphB4, to cross-react with murine ephrin-B2, and to induce internalization into ephrin-B2 expressing cells. EC8 was also compatible with immunoprecipitation and detection of ephrin-B2 expression in the tissue after standard chemical fixation procedure. Consistent with previous reports on ephrin-B2 induction in some epithelial tumors and tumor-associated vasculatures, EC8 specifically detected ephrin-B2 in tumors as well as the vasculature within and outside of the tumors. We envision that monoclonal antibody developed in this study may be used as a reagent to probe ephrin-B2 distribution in normal as well as in pathological conditions and to antagonize ephrin-B2 interaction with EphB4 for basic science and therapeutic applications.
UR - http://www.scopus.com/inward/record.url?scp=84856112433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856112433&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0030680
DO - 10.1371/journal.pone.0030680
M3 - Article
C2 - 22292016
AN - SCOPUS:84856112433
SN - 1932-6203
VL - 7
JO - PLoS ONE
JF - PLoS ONE
IS - 1
M1 - e30680
ER -